SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-21-066831
Filing Date
2021-12-22
Accepted
2021-12-22 06:03:23
Documents
18
Period of Report
2021-10-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea152864-8ka1_inmedphar.htm   iXBRL 8-K/A 38486
2 CONSENT OF HORNE LLP ea152864ex23-1_inmed.htm EX-23.1 1629
3 AUDITED FINANCIAL STATEMENTS OF BAYMEDICA, INC. FOR THE YEAR ENDED DECEMBER 31, ea152864ex99-1_inmed.htm EX-99.1 255225
4 UNAUDITED FINANCIAL STATEMENTS OF BAYMEDICA, INC. FOR THE NINE MONTHS ENDED SEPT ea152864ex99-2_inmed.htm EX-99.2 304510
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF INMED PHARMACEUT ea152864ex99-3_inmed.htm EX-99.3 158295
6 GRAPHIC ex99-1_001.jpg GRAPHIC 9720
  Complete submission text file 0001213900-21-066831.txt   1047663

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inm-20211013.xsd EX-101.SCH 3039
8 XBRL DEFINITION FILE inm-20211013_def.xml EX-101.DEF 26195
9 XBRL LABEL FILE inm-20211013_lab.xml EX-101.LAB 34476
10 XBRL PRESENTATION FILE inm-20211013_pre.xml EX-101.PRE 22600
12 EXTRACTED XBRL INSTANCE DOCUMENT ea152864-8ka1_inmedphar_htm.xml XML 3991
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39685 | Film No.: 211510956
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences